exploratory clinical study
Showing 1 - 25 of >10,000
Nasopharyngeal Carcinoma Trial in Wuhan (KSD-101)
Not yet recruiting
- Nasopharyngeal Carcinoma
- KSD-101
-
Wuhan, ChinaTongji Hospital, Tongji Medical College, Huazhong University of
Oct 19, 2023
EBV-associated Lymphomas Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell
Not yet recruiting
- EBV-associated Lymphomas
- (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
- (no location specified)
May 31, 2023
To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD Trial (LX109)
Not yet recruiting
- To Evaluate the Safety and Tolerability of Intravitreal Injection of LX109 in Patients With nAMD
- (no location specified)
Sep 1, 2023
Ulcerative Colitis Trial in Xi'an (G132 system, Beijing PINS Medical Co., China)
Not yet recruiting
- Ulcerative Colitis
- G132 system, Beijing PINS Medical Co., China
-
Xi'an, Shaanxi, ChinaXijing Hospital
Jun 8, 2023
Osteoarthritis, Knee Trial in Vejle (STEM-OA)
Not yet recruiting
- Osteoarthritis, Knee
- STEM-OA
-
Vejle, DenmarkSanos Clinic Syddanmark
Mar 16, 2023
Specificity of Magnetocardiogram in Atrial Fibrillation and
Recruiting
- Atrial Fibrillation
- Magnetocardiography
-
Hangzhou, Zhejiang, ChinaThe Second Affiliated Hospital, Zhejiang University School of Me
May 24, 2023
Locally Advanced Unresectable Gastric Cancer Trial in Guangzhou (Pemigatinib)
Not yet recruiting
- Locally Advanced Unresectable Gastric Cancer
-
Guangzhou, Guangdong, ChinaCancer center of SunYat-sen University
Aug 11, 2023
to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally
Recruiting
- to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
- Capecitabine 500Mg Oral Tablet
-
Shanghai, ChinaEye & ENT Hospital, Fudan University
Jul 2, 2023
Carcinoma Trial (Intravenous infusion anti-CEA-CAR-T cell)
Not yet recruiting
- Carcinoma
- Intravenous infusion anti-CEA-CAR-T cell
- (no location specified)
Aug 22, 2023
Wound Infection Trial in Hangzhou (antibacterial bone traction needles)
Recruiting
- Wound Infection
- antibacterial bone traction needles
-
Hangzhou, Zhejiang, ChinaZhaoming Ye
Feb 10, 2023
Cardiac Output Measurements, Healthy Subjects Trial in Leuven (Pulsify sensor, State-of-the-art ultrasound equipment)
Completed
- Cardiac Output Measurements
- Healthy Subjects
- Pulsify sensor
- State-of-the-art ultrasound equipment
-
Leuven, Vlaams-Brabant, BelgiumUZ Leuven
Feb 8, 2023
Systemic Lupus Erythematosus (SLE) Trial in Shanghai (anti-CD19 CAR NK cells (KN5501))
Recruiting
- Systemic Lupus Erythematosus (SLE)
- anti-CD19 CAR NK cells (KN5501)
-
Shanghai, ChinaChanghai Hospital
Aug 25, 2023
EBV-associated Haematologic Tumors Trial ((Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed
Not yet recruiting
- EBV-associated Haematologic Neoplasms
- (Autologous monocyte-derived DCs pulsed with allogeneic EBV-transformed B-lymphoblastoid cell line lysate
- (no location specified)
Dec 4, 2022
Solid Tumor Trial in Shanghai (GT201)
Recruiting
- Solid Tumor
- GT201
-
Shanghai, Shanghai, ChinaRenji Hospital Affiliated to Shanghai Jiaotong University School
Feb 1, 2023
Cholangiocarcinoma Trial (Hematoporphyrin Injection actived by photodynamic therapy combined with Sonodynamic Therapy)
Not yet recruiting
- Cholangiocarcinoma
- Hematoporphyrin Injection actived by photodynamic therapy combined with Sonodynamic Therapy
- (no location specified)
Nov 10, 2022
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
Gastric Cancer Trial in Qingdao (Chimeric antigen receptor T cell preparation targeting Claudin18.2)
Recruiting
- Gastric Cancer
- Chimeric antigen receptor T cell preparation targeting Claudin18.2
-
Qingdao, Shandong, ChinaThe Affiliated Hospital of Qingdao University
Jul 11, 2023
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
Aortic Valve Disease Trial in Vilnius (TRIFLO Heart Valve)
Not yet recruiting
- Aortic Valve Disease
- TRIFLO Heart Valve
-
Vilnius, LithuaniaVilnius University Hospital Santaros Klinikos
Nov 6, 2023
Atopic Dermatitis Trial in Glendale (NM26-2198, Placebo)
Recruiting
- Atopic Dermatitis
- NM26-2198
- Placebo
-
Glendale, CaliforniaCalifornia Clinical Trials Medical Group (CCTMG) managed by Pare
May 15, 2023
Male Androgenetic Alopecia Trial in Madrid (Dutasteride, Placebo)
Recruiting
- Male Androgenetic Alopecia
- Dutasteride
- Placebo
-
Madrid, SpainHospital Ramón y Cajal
Oct 25, 2022
Healthy Subject Trial in Seoul (Ursodeoxycholic Acid 250 Mg Oral Tablet)
Completed
- Healthy Subject
- Ursodeoxycholic Acid 250 Mg Oral Tablet
-
Seoul, Korea, Republic Of, Korea, Democratic People's Republic ofKyung Hee University Medical Hospital
Apr 16, 2023
Solid Tumor Trial in Tianjin (LM103)
Recruiting
- Solid Tumor
- LM103
-
Tianjin, ChinaTianjin Beichen Hospital
Jul 4, 2023
Relapsed and Refractory B-cell Lymphoma Trial (CD19 CAR-T and CD19 CAR-DC)
Not yet recruiting
- Relapsed and Refractory B-cell Lymphoma
- CD19 CAR-T and CD19 CAR-DC
- (no location specified)
Oct 16, 2022